ArticleEnvironment & health (Washington, D.C.)2024
Differential Occupational Health Risks between Methylated PAHs and PAHs: Monitoring 126 PAHs and 6 Oxidative Stress Markers in Paired Serum-Urine Samples.
Article in Environment & health (Washington, D.C.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hazards of polycyclic aromatic hydrocarbons (PAHs) on occupationally exposed population have been widely acknowledged. However, the occupational exposure risks associated their derivatives, methylated PAHs, remain poorly understood. This study conducted a screen of 126 PAHs and 6 oxidative stress biomarkers (OSBs) in paired serum-urine samples from 110 petrochemical workers to assess the risk associated with different PAHs exposure. The results showed that the median concentrations of unmetabolized 16 priority PAHs (p-PAHs), 16 regular PAHs (R-PAHs), 50 methyl-PAHs (Me-PAHs), and 30 nitro-PAHs (N-PAHs) in serum (urine) were 97.98 (66.46), 11.02 (0.00), 77.76 (31.77), and 1.93 (0.10) ng/mL, respectively. The median concentration of metabolized hydroxy PAHs (OH-PAHs) in urine was 12.00 ng/mL (9.49 ng/mg creatinine). OSBs indicate that the hazards of Me-PAHs on exposed populations manifest as protein damage, while the hazards of p-PAHs mainly result in lipid and DNA damage. Results from common diseases and PAH exposure demonstrate a correlation between liver damage and PAH exposure, and Me-PAHs are more difficult to metabolize through urine due to their stronger lipophilicity. This study suggests that traditional health screenings targeting p-PAHs may be insufficient and likely underestimate the exposure risks for occupational populations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.